Preliminary scientific tests suggest conolidine may well inhibit distinct ion channels, reducing neuronal excitability and limiting pain signals. This mechanism is particularly related in neuropathic pain, where irregular signaling triggers persistent distress. Furthermore, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral to pain perception. Computational... https://grahamr071luw5.topbloghub.com/profile